TODAY'S PAPER
Few Clouds 31° Good Afternoon
Few Clouds 31° Good Afternoon
BusinessPress Releases

U.S. Court Appoints Ernest Cory Lead Plaintiffs' Counsel In Viagra Melanoma MDL

The Honorable Richard Seeborg appointed Ernest Cory Lead Counsel for Plaintiffs in the federal multidistrict litigation in re: Viagra (Sildenafil Citrate) Products Liability Litigation MDL No.2691. Plaintiffs' lawsuits allege Pfizer Inc. knew Viagra posed a melanoma cancer risk but concealed facts about the drug's safety.

San Francisco, CA (PRWEB) June 17, 2016

The Honorable Richard Seeborg has appointed Ernest Cory Plaintiffs’ Lead Counsel in the federal multidistrict litigation, In re: Viagra (Sildenafil Citrate) Products Liability Litigation, MDL No. 2691. On June 15, 2016, In United States District Court in the Northern District of California, Judge Seeborg appointed fifteen attorneys from across the U.S., including Cory Watson, P.C. Principal Kristian Rasmussen to the Plaintiffs’ Executive Committee. The U.S. Judicial Panel on Multidistrict Litigation (JPML) had transferred all pending federal Viagra lawsuits across the country to Judge Seeborg’s court in the Northern District of California.

More than 150 federal cases from around the U.S. are consolidated in litigation alleging Pfizer Inc. failed to sufficiently test a potential link between the use of Viagra and the risk of deadly melanoma before the drug was approved by the FDA. Additionally, Plaintiffs allege that even when studies indicated a potential link between Viagra and an increased risk of melanoma, Pfizer Inc. failed to warn users about the risks associated with Viagra use.

Lead Counsel Ernest Cory, a founding principal of Cory Watson, P.C. in Birmingham, Alabama, is joined on the Plaintiffs’ leadership team by Cory Watson, P.C. Principal Kristian Rasmussen. Both attorneys have successfully represented plaintiffs in leadership positions involving pharmaceutical drugs and medical devices.

Cory Watson Attorneys is a nationally recognized leader in complex litigation including class actions and mass torts involving pharmaceutical drugs and defective medical devices. The firm’s attorneys are frequently appointed to serve in leadership positions in national mass tort litigation and have participated in litigation successfully settling cases involving more than one hundred brands of pharmaceutical drugs and defective medical devices. The firm has an extensive practice in environmental law and individual personal injury cases including those involving automobile accidents, products liability, sexual assault civil liability, catastrophic injury and wrongful death. Additional information is available at http://www.corywatson.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/2016/06/prweb13492091.htm

More news

Sorry to interrupt...

Your first 5 are free

Access to Newsday is free for Optimum customers.

Please enjoy 5 complimentary views to articles, photos, and videos during the next 30 days.

LOGIN SUBSCRIBE